SU
SBI US Gateway Fund
Activity from announced rounds
Activity in this selectionSeries B
SBI US Gateway Fund is the specified investment vehicle named by Sift and Typewriter.
Recorded funding activity
Sift develops peptide immunotherapies using AI and profiling. Typewriter develops RNA-based insertion of therapeutic genes. These financing relationships belong to the named vehicle rather than to every SBI group entity.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.